95 EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS

Journal article

Peer reviewed

D.R. Nelson, R.H. Ghalib, M. Sulkowski, E. Schiff, V. Rustgi, P.J. Pockros, C. Wang, G. Decosterd Kerhuel, P. Grosgurin, H. Porchet, …

Journal of hepatology, Vol.50, pp.S40-S40

2009-04

Metrics

3 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.125 Hepatitis; 1.125.83 HCV
Web Of Science research areas: Gastroenterology & Hepatology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 95 EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS
Creators: D.R. Nelson
R.H. Ghalib
M. Sulkowski
E. Schiff
V. Rustgi
P.J. Pockros
C. Wang
G. Decosterd Kerhuel
P. Grosgurin
H. Porchet
R. Crabbe
Publication Details: Journal of hepatology, Vol.50, pp.S40-S40
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031713464602976